Advertisement
GKOS vs GMED
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and GMED is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GKOS’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 0 green FA rating(s).
- GKOS’s FA Score: 0 green, 5 red.
- GMED’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GKOS’s TA Score shows that 3 TA indicator(s) are bullish while GMED’s TA Score has 4 bullish TA indicator(s).
- GKOS’s TA Score: 3 bullish, 5 bearish.
- GMED’s TA Score: 4 bullish, 5 bearish.
Price Growth
GKOS (@Medical/Nursing Services) experienced а -7.48% price change this week, while GMED (@Medical/Nursing Services) price change was -5.19% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.25%. For the same industry, the average monthly price growth was -0.64%, and the average quarterly price growth was +13.10%.
Reported Earning Dates
GKOS is expected to report earnings on Feb 17, 2026.
GMED is expected to report earnings on Feb 19, 2026.
Industries' Descriptions
@Medical/Nursing Services (-3.25% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| GKOS | GMED | GKOS / GMED | |
| Capitalization | 6.59B | 11.7B | 56% |
| EBITDA | -42.92M | 710M | -6% |
| Gain YTD | 1.559 | -0.286 | -544% |
| P/E Ratio | N/A | 28.17 | - |
| Revenue | 470M | 2.77B | 17% |
| Total Cash | 274M | 391M | 70% |
| Total Debt | 104M | 119M | 87% |
GKOS | GMED | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 71 | 69 | |
SMR RATING 1..100 | 95 | 70 | |
PRICE GROWTH RATING 1..100 | 45 | 43 | |
P/E GROWTH RATING 1..100 | 61 | 99 | |
SEASONALITY SCORE 1..100 | 90 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GMED's Valuation (74) in the Medical Specialties industry is in the same range as GKOS (93). This means that GMED’s stock grew similarly to GKOS’s over the last 12 months.
GMED's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as GKOS (71). This means that GMED’s stock grew similarly to GKOS’s over the last 12 months.
GMED's SMR Rating (70) in the Medical Specialties industry is in the same range as GKOS (95). This means that GMED’s stock grew similarly to GKOS’s over the last 12 months.
GMED's Price Growth Rating (43) in the Medical Specialties industry is in the same range as GKOS (45). This means that GMED’s stock grew similarly to GKOS’s over the last 12 months.
GKOS's P/E Growth Rating (61) in the Medical Specialties industry is somewhat better than the same rating for GMED (99). This means that GKOS’s stock grew somewhat faster than GMED’s over the last 12 months.
| GKOS | GMED | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 54% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 64% |
| Momentum ODDS (%) | 1 day ago 62% | 1 day ago 60% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 61% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 58% |
| Advances ODDS (%) | 15 days ago 76% | 15 days ago 65% |
| Declines ODDS (%) | 23 days ago 68% | 1 day ago 57% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 58% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 58% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICRNX | 10.40 | 0.10 | +0.97% |
| VY® CBRE Global Real Estate A | |||
| UPMMX | 54.11 | 0.15 | +0.28% |
| Victory Precious Metals & Minerals Cl A | |||
| ABVIX | 19.40 | 0.04 | +0.21% |
| AB Large Cap Value I | |||
| TRWFX | 26.85 | 0.05 | +0.19% |
| Transamerica International Equity R4 | |||
| CNPEX | 68.94 | -0.38 | -0.55% |
| American Funds New Perspective 529E | |||
GKOS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with GMED. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then GMED could also see price increases.
| Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
|---|---|---|---|---|
| GKOS | 100% | -2.94% | ||
| GMED - GKOS | 60% Loosely correlated | -0.45% | ||
| PEN - GKOS | 58% Loosely correlated | -4.52% | ||
| CERS - GKOS | 53% Loosely correlated | -2.14% | ||
| ISRG - GKOS | 51% Loosely correlated | -0.08% | ||
| IRMD - GKOS | 51% Loosely correlated | -4.22% | ||
More | ||||
GMED and
Correlation & Price change
A.I.dvisor indicates that over the last year, GMED has been closely correlated with SENS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GMED jumps, then SENS could also see price increases.
| Ticker / NAME | Correlation To GMED | 1D Price Change % | ||
|---|---|---|---|---|
| GMED | 100% | -0.45% | ||
| SENS - GMED | 71% Closely correlated | +1.40% | ||
| PAVM - GMED | 68% Closely correlated | +7.21% | ||
| AXGN - GMED | 67% Closely correlated | -2.81% | ||
| MOVE - GMED | 66% Loosely correlated | +4.87% | ||
| INBS - GMED | 64% Loosely correlated | -6.14% | ||
More | ||||